Boston Sci’s Wingspan Gets Limited Nat’l Coverage; Broad HDE Policy Will Wait
This article was originally published in The Gray Sheet
Executive Summary
Medicare will nationally cover intracranial stenting and angioplasty only in the controlled setting of FDA-cleared clinical trials, CMS says